Brief: Valion Bio Reports First Quarter 2026 Financial Results
14/05/2026 21:52
May 14 (Reuters) - Valion Bio Inc VBIO.O: VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS VALION BIO INC - Q1 2026 NET LOSS $2.23 PER SHARE Source text: ID:nPn28kJ3da Further company coverage: VBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital